CLPT Q3 2021 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$344M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+30.0% YoY

Gross Profit

$3M66.5% margin

Operating Income

-$4M-83.2% margin

Net Income

-$4M-87.0% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+34.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$586,000

Balance Sheet

Total Assets

$69M

Total Liabilities

$25M

Stockholders' Equity

$44M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+30.0%
Gross Profit	$3M	$3M	+16.2%
Operating Income	-$4M	-$1M	-199.1%
Net Income	-$4M	-$1M	-168.2%

Revenue Segments

Remaining Performance Obligations Capital Equipment-Related Service Revenue

$800,00089%

Capital Equipment Related Service Revenue

$100,00011%